$6.01 -0.47 (-7.25%)
2/10/2012 4:00 PM

Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Featured Broker Partners


Advertisement